Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection
- 5 September 2003
- Vol. 22 (3-4) , 439-446
- https://doi.org/10.1016/j.vaccine.2003.07.014
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic MiceJournal of Virology, 2001
- Immune therapy of hepatitis B virus chronic infectionHepatology, 2000
- A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virusHepatology, 1999
- Specific Vaccine Therapy in Chronic Hepatitis B: Induction of T Cell Proliferative Responses Specific for Envelope AntigensThe Journal of Infectious Diseases, 1999
- Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: Interaction with HLA and T-cell receptorHepatology, 1997
- Th1 and Th2 cells in the cure and pathogenesis of infectious diseasesCurrent Opinion in Infectious Diseases, 1995
- Specific vaccine therapy in chronic hepatitis B infectionThe Lancet, 1994
- Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in BacteriaJournal of General Virology, 1990
- T- and B-cell recognition of hepatitis B viral antigensImmunology Today, 1988
- Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virusCell, 1986